11 Stroke Clinical Trials in New Haven, CT (2026)

Q: How do I join a clinical trial in New Haven?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you.

Recruiting Stroke Studies in New Haven

NCT04994756Recruiting

Stroke Thrombectomy and Aneurysm Registry

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of bloo...

New Haven, CT40,000 participantsMedical University of South Carolina

View Study Details

NCT06289985Recruiting

StrokeNet Thrombectomy Endovascular Platform

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO)....

New Haven, CTNA1,600 participantsMedical University of South Carolina

View Study Details

NCT05911568Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the br...

New Haven, CT1,060 participantsUniversity of Cincinnati

View Study Details

NCT06094478Recruiting

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the fir...

New Haven, CTNA900 participantsUniversity of Chicago

View Study Details

NCT05338697Recruiting

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemo...

New Haven, CT657 participantsUniversity of Cincinnati

View Study Details

NCT03821129Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of tr...

New Haven, CTNA636 participantsW.L.Gore & Associates

View Study Details

NCT04130503Recruiting

The Recovery in Stroke Using PAP Study

The proposed study is a randomized controlled trial among an anicipated 180 participants with acute ischemic stroke and mod/severe OSA diagnosed by ambulatory polysomnography (PSG) comparing PAP treat...

New Haven, CTNA360 participantsYale University

View Study Details

NCT05907629Recruiting

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

CAPTIVA-MRI is an observational multimodal MR imaging study that is ancillary to the CAPTIVA trial \[a 3-arm, double-blind Phase III trial conducted at approximately 115 StrokeNet sites randomizing pa...

New Haven, CT300 participantsYale University

View Study Details

NCT05948566Recruiting

Strategy for Improving Stroke Treatment Response

SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alp...

New Haven, CTPHASE2300 participantsTranslational Sciences, Inc.

View Study Details

NCT06029491Recruiting

The Pivotal Study of RapidPulseTM Aspiration System

The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or...

New Haven, CTNA170 participantsRapidPulse, Inc

View Study Details

NCT05756257Recruiting

Blood Pressure Variability and Ischemic Stroke Outcome

The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To dete...

New Haven, CT150 participantsYale University

View Study Details

About Stroke Clinical Trials in New Haven

A stroke occurs when blood flow to part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. It is a leading cause of disability and death. Rapid treatment is critical, and prevention focuses on managing risk factors like hypertension and atrial fibrillation.

There are currently 11 stroke clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 46,133 participants. Research is being sponsored by Medical University of South Carolina, University of Cincinnati, University of Chicago and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Stroke Clinical Trials in New Haven — FAQ

Are there stroke clinical trials in New Haven?

Yes, there are 11 stroke clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What stroke treatments are being tested?

The 11 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for stroke.

Data updated July 17, 2026 from ClinicalTrials.gov